Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

Researchers found that lithium can suppress HIV reactivation in lab-grown human cells through an unexpected, ...

IMAGE DISTRIBUTED FOR AIDS HEALTHCARE FOUNDATION - Healthcare advocates from across Florida protest at the Florida Department ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Explore the potential of the HIV drug Maraviroc in slowing glioblastoma growth as discovered by McMaster University ...

Rahul Purwar, Founder & Chairman of ImmunoACT outlined expansion plans beyond Africa, targeting Eastern Europe, other European countries and eventually the United States.

PEPFAR continues to fulfill its mission. By expanding its scope, this administration could earn the badge of eradicating HIV/AIDS by 2030.

Prayagraj: As many as 7 of the 13 transgenders, who were lodged in Pratapgarh district jail on Sunday, have tested positive for HIV in the primary scr.